K562 In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)
CAT#: ITS-1022-YF117
Target Cell Organism: Human
Target Cell Alternative Name: K-562
Target Cell Name: K562
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide K562-based In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
K562
Target Cell Organism
Human
Target Cell Background
K562 cells are of the erythroleukemia type, and the cell line is derived from a 53-year-old female chronic myelogenous leukemia patient in blast crisis. The cells are non-adherent and rounded, are positive for the bcr:abl fusion gene, and bear some proteomic resemblance to both undifferentiated granulocytes and erythrocytes.
Target Cell Alternative Name
K-562
Related Diseases
Chronic Myeloid Leukemia; CML
Research Area
Oncology
Assay Name
In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)
Short Description
K562-cell based In Vitro (3)H-thymidine Incorporation Assay (Cell Proliferation)
Assay Description
The 3H-thymidine incorporation assay is one such assay that can detect newly synthesized DNA in cells. Cultured cells are mixed with 3H-thymidine (radioactive) and kept for a desired incubation period. Newly replicated DNA strands can incorporate 3H-thymidine during mitosis. A scintillation counter is necessary to detect the output. Direct measurement of proliferating cells is the main advantage of this assay. However, use of harmful radioactive substances and need of special equipment are considered as main disadvantages.
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.